HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
United States US States Dietary Supplements

Health, Beauty And Wellness News: Herbalife Beats Sales Forecast

This article was originally published in The Rose Sheet

  • News

Executive Summary

Herbalife beats net sales forecast; AHPA on board with Hemp Farming Act; and CHPA criticizes sunscreen bill passed in Hawaii.

You may also be interested in...



Herbalife Compensates Following Regulatory Scrutiny, Icahn's Takeover Play

Revamped compensation practices Herbalife agreed to implement as part of a settlement to end the FTC investigation are starting to bear fruit, says Co-President John DeSimone. Investor Carl Icahn, meanwhile, sold a large slice of his stake in the firm's recent share buy-back tender, ending this takeover leverage while remaining the largest shareholder.

Suns Sets In Hawaii On Sunscreens Containing Octinoxate, Oxybenzone

CBD Cancer Claim Gets NAD Attention: Health And Wellness News

NAD sends CBD oil cancer claim to FTC; Supplement OWL passes 10,000 at first anniversary; Herbalife Nutrition two-for-one stock split; and Après resumes shipping with funding.

Table

View full table

Topics

Tags:
United States US States Dietary Supplements
Latest Headlines

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

See All
UsernamePublicRestriction

Register

RS121601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By